第一单位:
Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France.
作者:
Manuel,Rodrigues [1]
;
Giulia,Vanoni [2]
;
Pierre,Loap [3]
;
Coraline,Dubot [1]
;
Eleonora,Timperi [2]
;
Mathieu,Minsat [3]
;
Louis,Bazire [3]
;
Catherine,Durdux [4]
;
Virginie,Fourchotte [5]
;
Enora,Laas [5]
;
Nicolas,Pouget [5]
;
Zahra,Castel-Ajgal [6]
;
Gregoire,Marret [6]
;
Laetitia,Lesage [7]
;
Didier,Meseure [7]
;
Anne,Vincent-Salomon [7]
;
Lolita,Lecompte [8]
;
Nicolas,Servant [8]
;
Sophie,Vacher [9]
;
Ivan,Bieche [9]
;
Caroline,Malhaire [10]
;
Virginie,Huchet [11]
;
Laurence,Champion [11]
;
Maud,Kamal [6]
;
Sebastian,Amigorena [2]
;
Olivier,Lantz [2]
;
Marion,Chevrier [12]
;
Emanuela,Romano [13]
作者单位:
Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France.
[1]
Center for Cancer Immunotherapy, INSERM U932, PSL Research University, Institut Curie, Paris, France.
[2]
Department of Radiation Oncology, Institut Curie, Paris & Saint Cloud, France.
[3]
Hôpital Européen Georges Pompidou, Department of Radiation Oncology, Paris, France.
[4]
Service of Breast and Gynecologic Surgery, Institut Curie, Paris, France.
[5]
Department of Drug Development and Innovation, Institut Curie, Paris, France.
[6]
Department of Pathology Institut Curie, Paris, France.;Centre d'Investigation Clinique Biothérapie, Institut Curie, Paris, France.
[7]
Institut Curie Bioinformatics Platform, INSERM U900, Mines ParisTech, Paris, 75005, France.
[8]
Pharmacogenomics Unit, Service of Genetics, Institut Curie, Paris, France.
[9]
Department of Radiology, Institut Curie, Paris, 75005, France.
[10]
Department of Nuclear Medicine, Institut Curie, Paris, 75005, France.
[11]
Service of Biostatistics, Institut Curie, Paris, 75005, France.
[12]
Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France. Emanuela.Romano@curie.fr.;Center for Cancer Immunotherapy, INSERM U932, PSL Research University, Institut Curie, Paris, France. Emanuela.Romano@curie.fr.
[13]
DOI
10.1038/s41467-023-39383-8
PMID
37349318
发布时间
2023-11-17